feed,title,long_url,short_url
Benzinga,Regeneron Highlights Its First Phase 2 Data To Build Case In CD20xC3 Bispecific Space,https://benzinga.com/general/biotech/22/12/30037258/regeneron-highlights-its-first-phase-2-data-to-build-case-in-cd20xc3-bispecific-space,https://da.gd/eMo9f
